XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 222,596 $ 293,828
Marketable securities 391,316 320,966
Prepaid expenses and other current assets 11,793 11,492
Total current assets 625,705 626,286
Restricted cash 279 466
Marketable securities, non-current 224,118 283,531
Other investments 47,001 47,001
Property and equipment, net 125,707 120,098
Operating lease right-of-use assets 45,725 46,541
Other non-current assets 3,568 3,483
Total assets 1,072,103 1,127,406
Current liabilities:    
Accounts payable 6,510 3,207
Accrued liabilities and other current liabilities 22,686 29,057
Success payment liabilities 5,635 9,486
Deferred revenue 6,224 4,988
Total current liabilities 41,055 46,738
Operating lease liabilities, non-current 67,475 66,650
Deferred revenue, non-current 77,871 79,665
Other non-current liabilities 4,453 4,566
Total liabilities 190,854 197,619
Commitments and contingencies (Note 12)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 10,000 shares authorized at March 31, 2022 and December 31, 2021; zero shares issued and outstanding at March 31, 2022 and December 31, 2021 0 0
Common stock, $0.0001 par value; 500,000 shares authorized at March 31, 2022 and December 31, 2021; 245,423 and 242,738 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 25 24
Additional paid-in capital 1,540,330 1,515,748
Accumulated other comprehensive loss (6,600) (1,623)
Accumulated deficit (652,506) (584,362)
Total stockholders’ equity 881,249 929,787
Total liabilities and stockholders’ equity $ 1,072,103 $ 1,127,406